Free Trial

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$1.10 -0.03 (-2.65%)
As of 04:00 PM Eastern

Recent Biodexa Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:23 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
06/02/2025
4:24 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/30/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
4:59 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
05/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/15/2025
4:16 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
7:31 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
04/29/2025
3:15 PM
Biodexa Pharmaceuticals (Filer)
Form POS AM
04/17/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:41 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM
Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM
Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
Want to front-run Warren Buffett? (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
01/08/2025
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM
Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM
Biodexa Pharmaceuticals (Filer)
Form 424B3
[No Brainer Gold Play]: “Show me a better investment.” (Ad)

A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Click here to get Garrett’s Top Four picks now.
08/12/2024
3:36 PM
Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM
Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM
Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM
Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM
Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM
Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BDRX) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners